Endophytic Mycoflora: Antibacterial Secondary Metabolites and Their Therapeutic Potential

Ravindra Prasad Aharwal,Suneel Kumar,Sardul Singh Sandhu

DOI: https://doi.org/10.1007/s40495-021-00261-w

2021-08-10

Current Pharmacology Reports

Abstract:Purpose of ReviewNowadays, the need of novel biological active compounds is growing as there is remarkable increase in antibiotic resistance developed in microbes. In the present time, the need of new active novel biological molecules is growing as there is remarkable increase in antibiotic resistance. Therefore, the main purpose of this review articles is to introduce endophytic mycoflora that play important role in production of secondary metabolites of pharmaceutical and agriculture interest that fight against various bacterial infections and diseases.Recent FindingsAccording to recent research, endophyte produces antibacterial compounds in the host via an alternative biochemical pathway. Endophytic mycoflora are rich source of metabolites that can be used in the treatment of a variety of bacterial diseases. As a result, the production of novel antibacterial compounds by these microbes can help to reduce the load of compound extraction from plants also helping to reduce plant biodiversity loss.SummaryThe current review summarizes the biodiversity of endophytic mycoflora, as well as their biological characteristics and host specificity. In addition, describe the pathways involved in the synthesis of antibacterial compounds from these fungi, as well as the mode of transmission and the various types of antibacterial secondary metabolites isolated from endophytic mycoflora.